Dian Baker1, Barbara Quinn2. 1. School of Nursing, California State University, Sacramento, Sacramento, CA. Electronic address: dibaker@csus.edu. 2. Integrated Quality Services, Sutter Medical Center, Sacramento, CA.
Abstract
BACKGROUND: Because nonventilator hospital-acquired pneumonia (NV-HAP) is understudied, our purpose was to determine the incidence, overall burden, and level of documented pneumonia preventive interventions of NV-HAP in 24 U.S. hospitals. METHODS: This retrospective chart review extracted NV-HAP cases as per the 2014 ICD-9-CM codes for pneumonia not present on admission and the 2013 Centers for Disease Control and Prevention case definition. Patient demographic data, outcomes, and documented preventive interventions were also collected. RESULTS: We found 1,300 NV-HAP patients who acquired NV-HAP (rate, 0.12-2.28 per 1,000 patient days) across the 21 hospitals that completed the data collection. Most NV-HAP infections (70.8%) were acquired outside of intensive care units (ICUs); 18.8% required transfer into the ICU. In the 24 hours prior to diagnosis, most of the patients did not have fundamental hospital care associated with pneumonia prevention. CONCLUSIONS: This multicenter, nationwide study highlights the significant burden of NV-HAP in the U.S. acute care hospital setting. We found that NV-HAP occurred on every hospital unit, including in younger, healthy patients. This indicates that although some patients are clearly at higher risk, all patients carry some NV-HAP risk. Therapeutic interventions aimed at NV-HAP prevention are frequently not provided for patients in acute care hospitals.
BACKGROUND: Because nonventilator hospital-acquired pneumonia (NV-HAP) is understudied, our purpose was to determine the incidence, overall burden, and level of documented pneumonia preventive interventions of NV-HAP in 24 U.S. hospitals. METHODS: This retrospective chart review extracted NV-HAP cases as per the 2014 ICD-9-CM codes for pneumonia not present on admission and the 2013 Centers for Disease Control and Prevention case definition. Patient demographic data, outcomes, and documented preventive interventions were also collected. RESULTS: We found 1,300 NV-HAP patients who acquired NV-HAP (rate, 0.12-2.28 per 1,000 patient days) across the 21 hospitals that completed the data collection. Most NV-HAP infections (70.8%) were acquired outside of intensive care units (ICUs); 18.8% required transfer into the ICU. In the 24 hours prior to diagnosis, most of the patients did not have fundamental hospital care associated with pneumonia prevention. CONCLUSIONS: This multicenter, nationwide study highlights the significant burden of NV-HAP in the U.S. acute care hospital setting. We found that NV-HAP occurred on every hospital unit, including in younger, healthy patients. This indicates that although some patients are clearly at higher risk, all patients carry some NV-HAP risk. Therapeutic interventions aimed at NV-HAP prevention are frequently not provided for patients in acute care hospitals.
Authors: Paula D Strassle; Emily E Sickbert-Bennett; Michael Klompas; Jennifer L Lund; Paul W Stewart; Ashley H Marx; Lauren M DiBiase; David J Weber Journal: Infect Control Hosp Epidemiol Date: 2019-10-29 Impact factor: 3.254
Authors: Barbara H Rosario; Humaira Shafi; Anthony C A Yii; Louis Y Tee; Arron S H Ang; Gek Kheng Png; Wendy S T Ang; Yan Qing Lee; Pei Ting Tan; Aniruddha Sahu; Lin Fang Zhou; Yi Ling Zheng; Roslinda Binte Slamat; Aza A M Taha Journal: Eur Geriatr Med Date: 2021-06-03 Impact factor: 1.710
Authors: Ana Lopez-de-Andres; Romana Albaladejo-Vicente; Javier de Miguel-Diez; Valentin Hernandez-Barrera; Zichen Ji; Jose J Zamorano-Leon; Marta Lopez-Herranz; Rodrigo Jimenez-Garcia Journal: BMJ Open Diabetes Res Care Date: 2020-06
Authors: Adrian Ceccato; Meropi Panagiotarakou; Otavio T Ranzani; Marta Martin-Fernandez; Raquel Almansa-Mora; Albert Gabarrus; Leticia Bueno; Catia Cilloniz; Adamantia Liapikou; Miquel Ferrer; Jesus F Bermejo-Martin; Antoni Torres Journal: J Clin Med Date: 2019-06-13 Impact factor: 4.241
Authors: A Wolfensberger; W Jakob; M Faes Hesse; S P Kuster; A H Meier; P W Schreiber; L Clack; H Sax Journal: Clin Microbiol Infect Date: 2019-03-25 Impact factor: 8.067